L-Isoleucine Powder for BCAA Blends and Muscle Recovery Formulas

L-Isoleucine is used primarily in sports nutrition, muscle recovery, endurance and strength products, usually as part of a balanced 2:1:1 BCAA blend with L-leucine and L-valine. As an essential branched-chain amino acid, it contributes to muscle protein metabolism, glucose uptake during exercise and energy production in skeletal muscle. Purecium supplies L-isoleucine as a 99% minimum USP/EP-grade crystalline powder produced by non-GMO fermentation for distributors, contract manufacturers, private-label producers and supplement brands.

Because the human body cannot synthesize isoleucine, it must be supplied through diet or supplementation, which is why it is classified as an essential amino acid. It is also one of the three branched-chain amino acids (with L-leucine and L-valine), a group defined by their branched side-chain structure and their unique property of being oxidized primarily in skeletal muscle rather than the liver, which underpins their role in sports nutrition.

Branched-chain amino acids, including isoleucine, are oxidized in skeletal muscle where they contribute to energy production during exercise and provide substrate for muscle protein metabolism. L-Isoleucine has a particularly distinct role in glucose uptake into muscle cells during exercise. Published clinical studies suggest that BCAA supplementation supports recovery from intense exercise and reduces exercise-induced muscle soreness, with the greatest effect when the three BCAAs are taken together.

The three BCAAs share a branched side-chain structure but have distinct roles. L-Leucine is the primary activator of muscle protein synthesis signaling, L-isoleucine supports glucose uptake and energy metabolism in muscle, and L-valine contributes to nitrogen balance and serves as an energy substrate during prolonged exercise. Sports formulas typically combine all three in a 2:1:1 ratio (leucine:isoleucine:valine) to cover the full BCAA profile.

In a standard 2:1:1 BCAA blend, a typical serving of 5 g to 7 g total BCAAs provides about 1.25 g to 1.75 g of L-isoleucine. In standalone or higher-dose formulas, L-isoleucine servings of 1 g to 2.5 g are common, taken around training. Formulators should set label strength according to destination-market regulations and the finished-product positioning.

A high-purity L-isoleucine should be assayed at 99.0% minimum on a dried basis against the USP-NF or EP monograph, with identification by infrared spectroscopy, specific optical rotation within the pharmacopeial range confirming the L-enantiomer, related substances and impurities controlled by HPLC, heavy metals within limits, conforming residual solvents and microbial counts within USP/EP limits. Purecium reports all of these on the batch Certificate of Analysis, including the assay method, production date and expiry date.

Yes. L-Isoleucine is recognized as GRAS by the FDA in the United States, is covered by USP-NF and European Pharmacopoeia monographs, and EFSA has assessed amino acids including isoleucine for use in food supplements. It is a normal dietary amino acid present in protein foods and is well tolerated at typical supplement servings. As with any ingredient, formulators should confirm destination-market practice for dosage and claim wording.

Only the L-enantiomer of isoleucine is used in human nutrition; the D-form is not metabolized through the BCAA pathways and is not appropriate for food supplements. Fermentation production inherently yields the L-enantiomer, and specific optical rotation measured against the pharmacopeial value confirms it on every batch. Buyers should always request the specific rotation result on the CoA and confirm the method.

Yes. L-Isoleucine is commonly paired with L-leucine and L-valine in BCAA blends, with electrolytes and carbohydrates in endurance formulas, and with citrulline, beta-alanine or creatine in pre- and intra-workout products. These combinations are standard in the sports-nutrition category and show no known negative interactions at label doses. Formulators should verify ingredient compatibility, particle-size matching and blend uniformity, and confirm label claims comply with destination-market regulations.

Yes. Purecium's L-isoleucine is manufactured by microbial fermentation from non-GMO plant-based sugars, with no animal-derived starting materials or enzymes of animal origin. It carries a clear vegan, non-GMO, allergen-free and gluten-free statement and is suitable for vegan and vegetarian formulations, including plant-based sports nutrition.

A professional supplier should provide a current specification sheet, a batch-specific Certificate of Analysis showing identification, assay (99.0% minimum), specific optical rotation, related substances by HPLC, heavy metals, residual solvents and microbial results, an SDS, allergen and gluten statements, and non-GMO declarations. Also request Kosher and Halal certificates, copies of the ISO 9001 and FSSC 22000 certificates, and stability data for registration purposes. Purecium provides this full documentation set on request for every shipment.

The minimum order quantity is 25 kg. The powder is packed in 25 kg drums with food-grade aluminum-foil inner bags, and samples and technical documentation are available before you commit. Standard production lead time is typically 7 to 15 working days after order confirmation, with faster dispatch for stocked items. For North American customers, Purecium holds inventory at its US warehouse, enabling pickup or delivery within approximately two days. Export documentation is prepared for every shipment.

Enantiomeric purity is verified primarily by specific optical rotation measured against the pharmacopeial monograph value for L-isoleucine, and confirmed by chiral HPLC when required. The L-enantiomer rotates plane-polarized light within a defined range that distinguishes it from the D-form and racemic mixtures. Fermentation production inherently yields the L-enantiomer, and every Purecium batch reports the specific rotation result on the CoA.

Store L-isoleucine in tightly sealed original containers in a cool, dry place below 25 degrees Celsius, protected from moisture. The crystalline powder is stable under these conditions, and shelf life is generally 36 months from the date of manufacture. Each shipment's CoA states the production date and expiry date for inventory planning.

Purecium supplies L-Isoleucine as a B2B raw material standardized to 99.0% minimum assay and produced to USP and EP standards via non-GMO fermentation, with specific optical rotation confirming L-enantiomeric purity on every batch. Every batch is released with a full Certificate of Analysis including related-substances testing by HPLC, an SDS and supporting documentation. The minimum order is 25 kg, inventory is staged at our US warehouse for two-day pickup, and global delivery covers Hong Kong, mainland China, the EU and beyond. For long-term supply relationships, Purecium provides consistent quality, batch traceability, regulatory documents and direct technical communication rather than one-off spot pricing.